Title (en)

USE OF THE L-ENANTIOMER OF CENTCHROMAN FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF BREAST CANCER

Title (de)

VERWENDUNG DES L-ENANTIOMEREN VON CENTCHROMAN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG ODER VORBEUGUNG DES BRUSTKREBSES

Title (fr)

UTILISATION DE L'ENANTIOMERE-L DE CENTCHROMANNE DANS LA FABRICATION D'UNE COMPOSITION PHARMACEUTIQUE SERVANT AU TRAITEMENT OU A LA PROPHYLAXIE DU CANCER DU SEIN

Publication

EP 0873119 A1 19981028 (EN)

Application

EP 97900199 A 19970109

Priority

• DK 9700007 W 19970109
• DK 77696 A 19960711
• US 1000096 P 19960111

Abstract (en)

[origin: WO9725034A1] The present invention provides a novel use of the l-enantiomer of centchroman or a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer.

IPC 1-7

A61K 31/40; A61K 31/35

IPC 8 full level

C07D 295/08 (2006.01); A61K 31/40 (2006.01); A61K 31/4025 (2006.01); A61P 35/00 (2006.01)

CPC (source: EP KR)

A61K 31/35 (2013.01 - KR); A61K 31/40 (2013.01 - KR); A61K 31/4025 (2013.01 - EP); A61P 35/00 (2017.12 - EP)

Citation (search report)

See references of WO 9725034A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9725034 A1 19970717; AU 1367197 A 19970801; BR 9706966 A 19990504; CA 2241462 A1 19970717; CZ 217198 A3 19981111; EP 0873119 A1 19981028; HU P9901633 A2 19991028; HU P9901633 A3 20000228; IL 124881 A0 19990126; JP 2001500101 A 20010109; KR 19990077157 A 19991025; NO 983177 L 19980710; PL 328135 A1 19990118

DOCDB simple family (application)

DK 9700007 W 19970109; AU 1367197 A 19970109; BR 9706966 A 19970109; CA 2241462 A 19970109; CZ 217198 A 19970109; EP 97900199 A 19970109; HU P9901633 A 19970109; IL 12488197 A 19970109; JP 52476797 A 19970109; KR 19980705295 A 19980710; NO 983177 A 19980710; PL 32813597 A 19970109